1589. Activity of Meropenem-Vaborbactam and Comparators against Globally Disseminated Klebsiella pneumoniae Sequence Type 258

BACKGROUND: Meropenem-vaborbactam (MVB) is a combination of a carbapenem and a b-lactamase inhibitor active against β-lactamases including serine carbapenemases. MVB recently was approved in the US and Europe for the treatment of complicated UTIs, including acute pyelonephritis, and is approved in E...

Descripción completa

Detalles Bibliográficos
Autores principales: Shorttidge, Dee, Deshpande, Lalitagauri M, Doyle, Timothy B, Streit, Jennifer M, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776461/
http://dx.doi.org/10.1093/ofid/ofaa439.1769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776461/
http://dx.doi.org/10.1093/ofid/ofaa439.1769

Ejemplares similares